NAMRU San Antonio Awarded Contract to Support DARPA‘s FSHARP Program with Independant Verification & Validation
Table of Contents
The Naval Medical Research unit san Antonio (NAMRU San Antonio) has been awarded a three-year contract to provide independent verification and validation (IV&V) support for the Defense Advanced Research Projects Agency’s (DARPA) Forward Surgical Hematology and Resuscitation Program (FSHARP). this partnership leverages NAMRU San Antonio’s expertise in trauma models and blood product evaluation to ensure the safety and efficacy of new hemorrhage resuscitation technologies for battlefield scenarios.
DARPA’s FSHARP Program: Advancing Battlefield resuscitation
DARPA’s FSHARP program focuses on developing and evaluating innovative approaches to improve the survival rates of wounded service members experiencing severe hemorrhage. hemorrhage, or severe bleeding, remains a leading cause of preventable death on the battlefield. FSHARP aims to address this critical need by accelerating the development of advanced resuscitation strategies and technologies. https://www.darpa.mil/program/forward-surgical-hematology-and-resuscitation
NAMRU San Antonio’s Role: Rigorous Evaluation and Expertise
NAMRU San Antonio’s selection as the IV&V partner highlights its unique capabilities and long-standing experience in combat casualty care research. According to Dr. Dao Ho, a research immunologist within the Command, Control & Combat operations Medicine (CCC&OM) directorate, “NAMRU San Antonio is the best option for IV&V support for DARPA as we have a strong team of subject matter experts and the required capabilities to perform rigorous evaluation of blood and blood products for DARPA programs.”
Specifically, NAMRU San Antonio will utilize its established trauma models and cell-based platforms to verify the safety and effectiveness of newly developed products intended for hemorrhage resuscitation in a battlefield environment. This independent assessment is crucial for ensuring that these technologies meet the stringent requirements for deployment and ultimately save lives.
NAMRU San Antonio is a key component of Navy Medicine Research & Development. The unit collaborates with a diverse network of partners – including civilian research institutions, academia, industry, and other government agencies – to advance scientific knowledge and support the Department of Defense’s objectives for a highly effective fighting force.
NAMRU San Antonio’s research areas encompass:
* Combat Casualty Care: Developing and evaluating strategies to improve the survival and recovery of wounded service members.
* Craniofacial Research: Advancing treatments for facial injuries sustained in combat.
* Directed Energy Research: Investigating the medical effects of directed energy technologies.
This broad research portfolio contributes to the overall health readiness and lethality of Navy, Marine Corps, and joint U.S. warfighters, both during routine operations and in expeditionary environments. https://www.med.navy.mil/NAMRU-San-Antonio/
Key Takeaways
* NAMRU San Antonio secured a three-year contract to provide IV&V support for DARPA’s FSHARP program.
* The partnership will focus on evaluating the safety and efficacy of new hemorrhage resuscitation technologies.
* NAMRU San Antonio’s expertise in trauma models and blood product evaluation was a key factor in the contract award.
* This collaboration underscores the importance of Navy Medicine Research & Development in supporting warfighter health and readiness.
This contract represents a notable chance for NAMRU San Antonio to contribute to the advancement of battlefield medicine and improve outcomes for wounded service members. As the FSHARP program progresses, NAMRU San Antonio’s rigorous evaluation will play a vital role in ensuring that the most promising technologies are translated into life-saving capabilities for those who serve.
Worth a look